Related Experiment Video
Updated: Jun 28, 2026
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
Published on: January 22, 2014
MicroRNA profiling in human medulloblastoma
Elisabetta Ferretti1, Enrico De Smaele, Agnese Po
1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Abstract:
Medulloblastoma is an aggressive brain malignancy with high incidence in childhood. Current treatment approaches have limited efficacy and severe side effects. Therefore, new risk-adapted therapeutic strategies based on molecular classification are required. MicroRNA expression analysis has emerged as a powerful tool to identify candidate molecules playing an important role in a large number of malignancies. However, no data are yet available on human primary medulloblastomas. A high throughput microRNA expression profiles was performed in human primary medulloblastoma specimens to investigate microRNA involvement in medulloblastoma carcinogenesis. We identified specific microRNA expression patterns which distinguish medulloblastoma differing in histotypes (anaplastic, classic and desmoplastic), in molecular features (ErbB2 or c-Myc overexpressing tumors) and in disease-risk stratification. MicroRNAs expression profile clearly differentiates medulloblastoma from either adult or fetal normal cerebellar tissues. Only a few microRNAs displayed upregulated expression, while most of them were downregulated in tumor samples, suggesting a tumor growth-inhibitory function. This property has been addressed for miR-9 and miR-125a, whose rescued expression promoted medulloblastoma cell growth arrest and apoptosis while targeting the proproliferative truncated TrkC isoform. In conclusion, misregulated microRNA expression profiles characterize human medulloblastomas, and may provide potential targets for novel therapeutic strategies.
Insights
MicroRNA expression profiles reveal distinct patterns in medulloblastoma, a common childhood brain cancer. Downregulated microRNAs suggest tumor growth inhibition, offering potential new therapeutic targets.
Area of Science:
- Neuro-oncology
- Molecular biology
- Genetics
Background:
- Medulloblastoma is a highly aggressive pediatric brain malignancy with limited treatment options.
- Current therapies for medulloblastoma are associated with significant side effects.
- Risk-adapted therapeutic strategies based on molecular classification are needed.
Purpose of the Study:
- To investigate the role of microRNA expression in medulloblastoma development and progression.
- To identify specific microRNA signatures associated with different medulloblastoma subtypes and risk groups.
- To explore microRNAs as potential therapeutic targets for medulloblastoma.
Main Methods:
- High-throughput microRNA expression profiling of human primary medulloblastoma specimens.
- Comparative analysis of microRNA expression between tumor tissues and normal cerebellar tissues (adult and fetal).
- Functional analysis of specific microRNAs (miR-9 and miR-125a) in medulloblastoma cell lines.
Main Results:
- Distinct microRNA expression patterns were identified in medulloblastomas, differentiating them by histotype, molecular features (ErbB2, c-Myc), and risk stratification.
- Medulloblastomas showed significantly different microRNA profiles compared to normal cerebellar tissues.
- Most microRNAs were downregulated in tumors, suggesting a tumor suppressive role. Rescued expression of miR-9 and miR-125a induced cell growth arrest and apoptosis by targeting the truncated TrkC isoform.
Conclusions:
- Misregulated microRNA expression is a hallmark of human medulloblastomas.
- Specific microRNA profiles can serve as biomarkers for medulloblastoma classification and risk stratification.
- MicroRNAs, particularly downregulated ones like miR-9 and miR-125a, represent promising targets for novel medulloblastoma therapies.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs